TrialJAMA network open2024

Extended-Release 7-Day Injectable Buprenorphine for Patients With Minimal to Mild Opioid Withdrawal.

Gail D'Onofrio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.